KPP Advisory Services’s Moderna MRNA Stock Holding History

KPP Advisory Services’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$215K	Buy	+1,115	New	+$120K	0.04%	301

Other funds holding MRNA

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Beau Ventures, LLc Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

LAI

Legal Advantage Investments Los Altos Hills, California $468M AUM 7.83% 1-Year Est. Return

KPP Advisory Services's MRNA Position: Q3 2026 in Review

KPP Advisory Services opened a new position in Moderna (MRNA) in Q3 2026: 1,115 shares worth $215K. The stake represents 0.04% of the portfolio and ranks #301 among its holdings.

278 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

KPP Advisory Services held 1,115 shares of Moderna worth $215K as of Q3 2026.
Moderna was a new KPP Advisory Services position in Q3 2026.
Moderna made up 0.04% of KPP Advisory Services's portfolio in Q3 2026, its #301 holding.
278 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on KPP Advisory Services's 13F filing for Q3 2026, filed 26 Oct 2026.